Cargando…

Correction: A Multi-Parametric Imaging Investigation of the Response of C6 Glioma Xenografts to MLN0518 (Tandutinib) Treatment

Detalles Bibliográficos
Autores principales:	Boult, Jessica K. R., Terkelsen, Jennifer, Walker-Samuel, Simon, Bradley, Daniel P., Robinson, Simon P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776888/ http://dx.doi.org/10.1371/annotation/37d4affb-9a93-44f3-8546-ad9cc07c7805

Ejemplares similares

A Multi-Parametric Imaging Investigation of the Response of C6 Glioma Xenografts to MLN0518 (Tandutinib) Treatment
por: Boult, Jessica K. R., et al.
Publicado: (2013)

Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)
por: DENG, WEN, et al.
Publicado: (2013)

Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI
por: Burrell, Jake S., et al.
Publicado: (2016)

MRI measurements of vessel calibre in tumour xenografts: Comparison with vascular corrosion casting
por: Burrell, Jake S., et al.
Publicado: (2012)

P.0518 Effects of COVID-19 lockdowns on well-being in subgroups of the population
por: Lan, A., et al.
Publicado: (2021)

The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
por: Lauté-Caly, Delphine L., et al.
Publicado: (2019)

Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI
por: Boult, Jessica K.R., et al.
Publicado: (2017)

MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
por: Sells, Todd B., et al.
Publicado: (2015)

P05.18. Mixed methods approaches in whole systems research: a study of Ayurvedic diagnostics
por: Dhruva, A, et al.
Publicado: (2012)

The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity
por: Malhab, Lara J. Bou, et al.
Publicado: (2016)

Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth
por: Kannan, Aarthi, et al.
Publicado: (2015)

LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay
por: Attwa, Mohamed W, et al.
Publicado: (2020)

RTOG 0518: Randomized Phase III Trial to Evaluate Zoledronic Acid for Prevention of Osteoporosis and Associated Fractures in Prostate Cancer Patients
por: Kachnic, Lisa A., et al.
Publicado: (2013)

Sequential multi-parametric MRI in assessment of the histological subtype and features in the malignant pleural mesothelioma xenografts
por: Zhang, Zhenghua, et al.
Publicado: (2023)

Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment
por: Filippova, Natalia, et al.
Publicado: (2018)

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
por: Gay, Carl M., et al.
Publicado: (2020)

Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer
por: Ferris, Jennifer, et al.
Publicado: (2020)

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy
por: Arighi, Andrea, et al.
Publicado: (2015)

Broad and potent antiviral activity of the NAE inhibitor MLN4924
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2016)

The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis
por: Wolenski, F S, et al.
Publicado: (2015)

DDEL-06. Drug Delivery to the Pons Using Short-Pulse Focused Ultrasound and Microbubble Exposure for the Treatment of Diffuse Midline Glioma
por: Chattenton, Dani, et al.
Publicado: (2022)

Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
por: Caro-Vegas, Carolina, et al.
Publicado: (2019)

MLN51 Stimulates the RNA-Helicase Activity of eIF4AIII
por: Noble, Christian G., et al.
Publicado: (2007)

Hybrid Breeding for MLN Resistance: Heterosis, Combining Ability, and Hybrid Prediction
por: Nyaga, Christine, et al.
Publicado: (2020)

The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance
por: Du, Meng-ge, et al.
Publicado: (2021)

Functional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses
por: Yao, Nai-Wei, et al.
Publicado: (2016)

Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors
por: Falchook, Gerald S., et al.
Publicado: (2015)

Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
por: Wang, Xiaofang, et al.
Publicado: (2016)

Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd‐DTPA and USPIO‐enhanced imaging
por: Boult, Jessica K.R., et al.
Publicado: (2016)

Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma
por: Baker, Lauren C. J., et al.
Publicado: (2018)

IMG-09. Characterisation of a panel ofin vivo models of paediatric-type diffuse high-grade glioma (PDHGG) using magnetic resonance imaging
por: Boult, Jessica, et al.
Publicado: (2022)

The novel protective role of P27 in MLN4924-treated gastric cancer cells
por: Zhang, Q, et al.
Publicado: (2015)

Preclinical transgenic and patient‐derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma
por: Boult, Jessica K. R., et al.
Publicado: (2017)

The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma
por: Suarez, Lorena P., et al.
Publicado: (2016)

The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme
por: Yang, Dong, et al.
Publicado: (2012)

CERN: servono 20-26 mln euro per riparare acceleratore LHC
Publicado: (2009)

MLN64 induces mitochondrial dysfunction associated with increased mitochondrial cholesterol content
por: Balboa, Elisa, et al.
Publicado: (2017)

Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib
por: Yang, Zelong, et al.
Publicado: (2019)

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma
por: Lyons Rimmer, Jade, et al.
Publicado: (2020)

Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1
por: Mao, Hongmei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_don57qnfksa1ivdmcii7g3pdle